chronic lymphocytic leukemia造句
1. Lymph node enlargement occurs early in chronic lymphocytic leukemia.
2. "Chronic" leukemias have few or no blast cells. "Chronic lymphocytic leukemia" and "chronic myelogenous leukemia" usually progress slowly compared to acute leukemias.
3. Background: A diagnosis of chronic lymphocytic leukemia (CLL) requires a count of over 5000 circulating CLL-phenotype cells per cubic millimeter.
4. Said was diagnosed with chronic lymphocytic leukemia in 1991, a malignant cancer of the bone marrow and blood.
5. Using the test, they found that chronic lymphocytic leukemia (CLL) is an "easy mark" for the experimental drug ABT-737.
6. We describe a patient with concomitant B-cell chronic lymphocytic leukemia (CLL) and multiple myeloma (MM).
7. Objective: To improve the understanding of chronic lymphocytic leukemia who transformed to highly aggressive hematologic malignant tumors.
8. Chronic lymphocytic leukemia and chronic myelogenous leukemia usually progress slowly compared to acute leukemias.
9. In chronic lymphocytic leukemia (CLL), the leukemia cell that starts the disease makes too many lymphocytes that do not function.
10. CD 117 was negative in CML in chronic phase and chronic lymphocytic leukemia.
11. Objective To investigate the characteristics of immunophenotype of B chronic lymphocytic leukemia(B-CLL) and to evaluate the value of ZAP-70 and CD38 in diagnosis and prognosis of B-CLL.
12. Very low gamma globulins are a frequent feature of chronic lymphocytic leukemia.
13. Objective To explore the effects of various factors affecting apoptosis of chronic lymphocytic leukemia (CLL) cells mediated by P2Z purinoceptor.
14. The study was aimed to investigate the immunophenotypic and cytogenetic features of chronic lymphocytic leukemia in order to provide an evidence for diagnosis and therapy.
15. A transplant of healthy bone marrow from a donor has been the only treatment and potential cure for chronic lymphocytic leukemia.
16. Objective To explore the molecular cytogenetic characteristics in patients with chronic lymphocytic leukemia.
17. Objective To investigate the efficacy and safety of combined fludarabine and rituximab therapy for chronic lymphocytic leukemia in old patients.
18. Rituxan is currently approved as a treatment for non-Hodgkin's lymphoma, chronic lymphocytic leukemia and rheumatoid arthritis.